Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Previously Published on Genprex.com — Genprex, Inc. (“Genprex” or the “Company”) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that data highlighting the potential of Genprex’s gene therapy for Type 1 diabetes is being presented by its research collaborators at the University of Pittsburgh (Pitt) at the 16th International…

Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M

Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M

Previously Published on Fiercebiotech.com – Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday throws a net around ViaCyte’s stem cell-based treatment for type 1 diabetes, which has…

Bionic Pancreas Removes Math from Diabetes Process

Bionic Pancreas Removes Math from Diabetes Process

Previously Published on medwireNews – The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial. Bionic pancreas removes math from diabetes. Instead of counting carbohydrates, users of the Beta Bionics iLet insulin-only bionic pancreas just make meal announcements with the modifier of…

Colorado Researchers Working Toward A Cure For Type 1 Diabetes
|

Colorado Researchers Working Toward A Cure For Type 1 Diabetes

Previously Published on denver.cbslocal.com – Some of the most advanced research in diabetes is being done right here in Colorado. The Barbara Davis Center is world renowned for the care and research of Type 1 diabetes. On the first floor at the center, doctors provide care to patients. In the labs on the upper floors, researchers…

A Cure for Type 1 Diabetes? It Has Worked for One Man
|

A Cure for Type 1 Diabetes? It Has Worked for One Man

Previously Published on dnyuz.com – Brian Shelton’s life was ruled by Type 1 diabetes. Could it be a cure for Type 1 Diabetes? It Has Worked for One Man. When his blood sugar plummeted, he would lose consciousness without warning. He crashed his motorcycle into a wall. He passed out in a customer’s yard while delivering mail….

Ketogenic Lifestyle is Beneficial for People with Type 1 Diabetes
|

New Study: Ketogenic Lifestyle is Beneficial for People with T1D

Previously published on Diabetestimes.co.uk – People with type 1 diabetes can benefit from a ketogenic lifestyle just as much as those without the condition. This new study was reported in the journal Endocrinology, Diabetes and Obesity. The feasibility of exercising over five days while fasting, in those with and without t1d mellitus, tested during the study. Academic, Ian Lake, analyzed…

Implant Reverses Type 1 Diabetes in Mice by Delivering Beta Cells
|

Implant Reverses Type 1 Diabetes in Mice by Delivering Beta Cells

Previously Published on Medical News Today – New research uses stem cells and a tiny device, the implant reverses type 1 diabetes in mice. Insulin-secreting beta cells can reverse type 1 diabetes in mice. Introducing these cells without triggering the immune system has been a critical challenge. Researchers have developed an apparently safe, functional device for delivery…

FDA Endorses Teplizumab for Delaying Type 1 Diabetes

FDA Endorses Teplizumab for Delaying Type 1 Diabetes

Previously Published on Medscape.com – A US Food and Drug Administration (FDA) advisory panel has voted narrowly to recommend approval of the monoclonal antibody teplizumab (Tzield,Provention Bio) for the delay of type 1 diabetes in at-risk individuals. (FDA Endorses Teplizumab) The 10-7 vote of the FDA’s Endocrinologic and Metabolic Drugs advisory committee on May 27 reflected a…